What is the cause of incomplete testicular descent?

Incomplete testicular descent actually refers to the problem of testicular descent obstruction. During the descent process, the testicles are unable to enter the scrotum. Sometimes these are caused by congenital diseases. In fact, they should not be ignored and must be treated in time to avoid malignancy into testicular tumors.

1. Incomplete testicular descent refers to the descent of the testicles, which stay in the middle of the descent process and fail to enter the scrotum. It is also commonly called cryptorchidism in clinical practice. Cryptorchidism is a congenital disease. The occurrence of cryptorchidism is related to hormone levels, testicular fascia and short spermatic cord. Cryptorchidism often occurs on one side, and the incidence of bilateral cryptorchidism is about 10-25%.

2. Cryptotestis is often accompanied by inguinal oblique hernia. Cryptotestis that stay in the abdominal cavity or inguinal area, because the temperature is higher than that of the scrotum, the testicles are in this environment for a long time, which leads to poor development and degeneration of the seminiferous tubules, causing spermatogenesis dysfunction. Over time, in puberty, cryptotestis will also degenerate into testicular tumors. Therefore, cryptotestis should be treated early and retracted into the scrotum to avoid complications.

3. Cryptorchidism should be treated and relocated before the age of 2, and no later than 5-6 years old.

4. Patients with bilateral cryptic testis should be treated with human chorionic gonadotropin (HCG) or gonadotropin-releasing hormone (LHRH) before surgery, which can promote the descent of cryptic testis.

5. Treat inguinal oblique hernia while performing secret testicular release and fixation.

6. If the testicle is found to be underdeveloped or suspected of malignancy, or if an adult has unilateral cryptic testis, surgical removal is recommended.

7. For children with occult testis, whether unilateral or bilateral, LARH spray can be applied full-time from 10 months, 400μg each time, 3-4 times a day, for 4 weeks. If it is unsuccessful, H.C.G can be used continuously, with a weekly intramuscular injection of 1500u for 3 weeks, and the success rate of testicular descent can reach 73%.

8. If endocrine therapy is ineffective, surgical treatment should be considered.

9. To increase the number of reproductive cells after surgery, Buserelin can be used immediately, which will help improve fertility in the future.